Clinical Laserthermia Systems AB (publ) (ST:CLS-B) — Market Cap & Net Worth
Market Cap & Net Worth: Clinical Laserthermia Systems AB (publ) (CLS-B)
Clinical Laserthermia Systems AB (publ) (ST:CLS-B) has a market capitalization of $9.40 Million (Skr87.33 Million) as of September 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #27328 globally and #595 in its home market, demonstrating a -5.76% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Clinical Laserthermia Systems AB (publ)'s stock price Skr1.80 by its total outstanding shares 48516242 (48.52 Million). Also see CLS-B total assets for a full breakdown of the balance sheet.
Clinical Laserthermia Systems AB (publ) Market Cap History: 2015 to 2026
Clinical Laserthermia Systems AB (publ)'s market capitalization history from 2015 to 2026. Data shows change from $2.32 Billion to $9.40 Million (-40.66% CAGR). Also see cash efficiency ratio of Clinical Laserthermia Systems AB (publ) for how efficiently the company converts equity into cash flow.
Clinical Laserthermia Systems AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Clinical Laserthermia Systems AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check CLS-B stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
2.05x
Clinical Laserthermia Systems AB (publ)'s market cap is 2.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.59 Billion | $3.64 Million | -$26.95 Million | 713.38x | N/A |
| 2017 | $4.04 Billion | $614.45K | -$21.26 Million | 6581.85x | N/A |
| 2018 | $1.84 Billion | $1.81 Million | -$32.85 Million | 1019.84x | N/A |
| 2019 | $1.58 Billion | $1.43 Million | -$43.38 Million | 1110.37x | N/A |
| 2020 | $1.22 Billion | $1.33 Million | -$57.94 Million | 919.46x | N/A |
| 2021 | $1.12 Billion | $2.25 Million | -$63.62 Million | 500.44x | N/A |
| 2022 | $277.87 Million | $6.27 Million | -$70.66 Million | 44.33x | N/A |
| 2023 | $144.10 Million | $8.27 Million | -$79.79 Million | 17.42x | N/A |
| 2024 | $19.11 Million | $18.78 Million | -$47.62 Million | 1.02x | N/A |
| 2025 | $35.92 Million | $17.49 Million | -$41.61 Million | 2.05x | N/A |
Competitor Companies of CLS-B by Market Capitalization
Companies near Clinical Laserthermia Systems AB (publ) in the global market cap rankings as of September 19, 2026. Review Clinical Laserthermia Systems AB (publ) tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Clinical Laserthermia Systems AB (publ) by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $178.43 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #238 globally with a market cap of $105.53 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $178.43 Billion | $102.61 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.13 |
| #238 | Stryker Corporation | NYSE:SYK | $105.53 Billion | $275.12 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Clinical Laserthermia Systems AB (publ) Historical Marketcap From 2015 to 2026
Between 2015 and today, Clinical Laserthermia Systems AB (publ)'s market cap moved from $2.32 Billion to $ 9.40 Million, with a yearly change of -40.66%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr9.40 Million | -73.84% |
| 2025 | Skr35.92 Million | +87.98% |
| 2024 | Skr19.11 Million | -86.74% |
| 2023 | Skr144.10 Million | -48.14% |
| 2022 | Skr277.87 Million | -75.27% |
| 2021 | Skr1.12 Billion | -8.27% |
| 2020 | Skr1.22 Billion | -22.65% |
| 2019 | Skr1.58 Billion | -14.13% |
| 2018 | Skr1.84 Billion | -54.41% |
| 2017 | Skr4.04 Billion | +55.87% |
| 2016 | Skr2.59 Billion | +11.90% |
| 2015 | Skr2.32 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Clinical Laserthermia Systems AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.40 Million USD |
| MoneyControl | $9.40 Million USD |
| MarketWatch | $9.40 Million USD |
| marketcap.company | $9.40 Million USD |
| Reuters | $9.40 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Clinical Laserthermia Systems AB (publ)
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control trea… Read more